In Adoptive CAR-T technology, there are plenty of papers using whole genome CRISPR KO on target tumor, looking for immunomodulators in cancer tussue. BUT I couldn't find ANY papers using WG KO on CAR-T themself looking for immunomodulators such as PD1 ets. Why??

More Dmitry Guschin's questions See All
Similar questions and discussions